Indian Pharmacopoeia Commission (IPC) and UPPPC have signed an MoU to improve the pharma and medical device sector in UP. Its objective is to promote quality, regulatory compliance and innovation.
New Delhi [भारत]July 15 (ANI): In a major step towards advancing high-quality standards of healthcare services and strengthening the regulatory framework, the Indian Pharmacopoeia Commission (IPC) has signed a Memorandum of Understanding (MoU) with the Uttar Pradesh Promote Pharma Council (UPPPC). This information was given through a release.
The MoU was signed during the ‘YEIDA MedTech Investors Meet & Site Visit 2026’ held at India Expo Mart, Greater Noida on 14th July 2026. This strategic collaboration aims to strengthen the pharmaceutical and medical device ecosystem by promoting quality standards, regulatory excellence, innovation and capacity building across the sector.
What is the purpose of partnership?
Through this partnership, IPC and UPPPC will work together to strengthen quality standards and regulatory compliance in the pharmaceutical and medical device industries. This collaboration will also promote awareness about Indian Pharmacopoeia, Pharmacovigilance and Materiovigilance.
Both the bodies will organize joint training programmes, workshops and awareness initiatives for stakeholders. The MoU also aims to promote research, innovation and industry-academia collaboration. To support MSMEs, digital tools for reporting adverse events will be made available.
The partnership will also enhance patient safety through quality assurance and post-market surveillance initiatives. This MoU reflects IPC’s continued commitment to advancing high-quality healthcare standards, supporting innovation and strengthening India’s regulatory framework. Additionally, it will also contribute to developing Uttar Pradesh as a major hub for pharmaceuticals, medical devices and healthcare technologies.
This partnership strives to create a strong ecosystem that promotes quality, safety, innovation and global competitiveness. (ANI)
(Except for the headline, this story has not been edited by Asianetnews Editorial staff and is published from a syndicated feed.)